Decreased cell viability of gastric cancer cells by evodiamine treatment was mediated by activation of caspase-3, caspase-7, caspase-8, and caspase-9; cleavage of PARP; and subsequent induction of apoptosis. Here, CASP7 is linked to gastric cancer.